Anti-SARS-CoV-2 Immunoglobulin G Antibody Titers in Contemporary Lots of Intravenous Immunoglobulin and Fresh Frozen Plasma Compared With COVID-19 Convalescent Plasma.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 39895318.
- Also identified by DOI 10.1093/cid/ciaf045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Given declining coronavirus disease 2019 convalescent plasma (CCP) collection and increasing scarcity, we compared anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody titers between CCP, intravenous immunoglobulin, and fresh frozen plasma. Herein, we report comparative anti-SARS-CoV-2 IgG antibody titers between 5 lots of each blood product, using the DiaSorin Liaison SARS-CoV-2 TrimericS IgG assay.
Medical subject headings
- Immunoglobulins, Intravenous
- Immunoglobulin G
- Antibodies, Viral
- SARS-CoV-2
- Plasma
- COVID-19